Published in Inflammation on October 01, 2003
A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature (1994) 9.31
Matrix metalloproteinases: structures, evolution, and diversification. FASEB J (1998) 2.74
Bradykinin-induced bronchoconstriction in humans. Mode of action. Am Rev Respir Dis (1987) 2.64
A smooth muscle-specific monoclonal antibody recognizes smooth muscle actin isozymes. J Cell Biol (1985) 2.38
The B1 receptors for kinins. Pharmacol Rev (1998) 2.32
Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. J Allergy Clin Immunol (1999) 2.04
Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med (1985) 1.84
Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone. Br J Pharmacol (1994) 1.82
Detection of tissue kallikrein in the bronchoalveolar lavage fluid of asthmatic subjects. J Clin Invest (1987) 1.80
Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes. J Clin Invest (1994) 1.74
Actions of some peptides on bronchial muscle. Br J Pharmacol Chemother (1962) 1.46
Nasal provocation with bradykinin induces symptoms of rhinitis and a sore throat. Am Rev Respir Dis (1988) 1.43
Bradykinin-induced contraction of human peripheral airways mediated by both bradykinin beta 2 and thromboxane prostanoid receptors. Am J Respir Crit Care Med (1994) 1.41
New selective bradykinin receptor antagonists and bradykinin B2 receptor characterization. Trends Pharmacol Sci (1990) 1.40
Evidence for participation of B1 and B2 kinin receptors in formalin-induced nociceptive response in the mouse. Br J Pharmacol (1993) 1.39
Inhibition of matrix metalloproteinases prevents allergen-induced airway inflammation in a murine model of asthma. J Immunol (1999) 1.38
Involvement of gelatinases (MMP-2 and MMP-9) in the development of airway inflammation and pulmonary fibrosis. Cell Biol Toxicol (2002) 1.36
Elevation of tissue kallikrein and kinin in the airways of asthmatic subjects after endobronchial allergen challenge. Am Rev Respir Dis (1992) 1.21
Induction of MMP-9 in normal human bronchial epithelial cells by TNF-alpha via NF-kappa B-mediated pathway. Am J Physiol Lung Cell Mol Physiol (2001) 1.02
Prostaglandins increase proMMP-1 and proMMP-3 secretion by human ciliary smooth muscle cells. Curr Eye Res (1996) 1.02
Comparative airway response to inhaled bradykinin, kallidin, and [des-Arg9]bradykinin in normal and asthmatic subjects. Am Rev Respir Dis (1990) 1.01
Bradykinin and respiratory mucous membranes. Analysis of bradykinin binding site distribution and secretory responses in vitro and in vivo. Am Rev Respir Dis (1990) 1.00
Effects of transforming growth factor beta and interleukin-1 beta on expression of cyclooxygenase 1 and 2 and phospholipase A2 mRNA in lung fibroblasts and endothelial cells in culture. Biochem Biophys Res Commun (1993) 1.00
Influx of kininogens into nasal secretions after antigen challenge of allergic individuals. J Clin Invest (1985) 0.99
Induction of vascular smooth muscle bradykinin B1 receptors in vivo during antigen arthritis. Agents Actions (1991) 0.98
A bradykinin-antagonist blocks antigen-induced airway hyperresponsiveness and inflammation in sheep. Pulm Pharmacol (1990) 0.97
Interleukin-1beta and tumor necrosis factor-alpha induce chemokine and matrix metalloproteinase gene expression in human colonic subepithelial myofibroblasts. Scand J Gastroenterol (2002) 0.97
Autocrine production of matrix metalloproteinase-2 is required for human airway smooth muscle proliferation. Am J Physiol (1999) 0.94
PGE2 release by bradykinin in human airway smooth muscle cells: involvement of cyclooxygenase-2 induction. Am J Physiol (1997) 0.93
Eosinophil inflammation of nasal polyp tissue: relationships with matrix metalloproteinases, tissue inhibitor of metalloproteinase-1, and transforming growth factor-beta1. J Korean Med Sci (2003) 0.93
Effects of bradykinin receptor antagonists on antigen-induced respiratory distress, airway hyperresponsiveness and eosinophilia in guinea-pigs. Br J Pharmacol (1992) 0.91
Bradykinin stimulates IL-8 production in cultured human airway smooth muscle cells: role of cyclooxygenase products. J Immunol (1998) 0.90
Influence of cytokines on matrix metalloproteinases produced by fibroblasts cultured in monolayer and collagen gels. J Formos Med Assoc (2001) 0.88
Role of bradykinin B(1) receptors in diabetes-induced hyperalgesia in streptozotocin-treated mice. Eur J Pharmacol (2002) 0.87
Bradykinin stimulates alveolar macrophages to release neutrophil, monocyte, and eosinophil chemotactic activity. J Immunol (1996) 0.86
Involvement of bradykinin B1 and B2 receptors in pulmonary leukocyte accumulation induced by Sephadex beads in guinea pigs. Eur J Pharmacol (1999) 0.86
The kallikrein-kininogen-kinin system in chronic inflammation. Agents Actions (1989) 0.86
Secretory non-pancreatic phospholipase A2 and cyclooxygenase-2 expression by tracheobronchial smooth muscle cells. Eur J Biochem (1996) 0.86
Effect of bradykinin, TGF-beta1, IL-1beta, and hypoxia on COX-2 expression in pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol (2002) 0.86
S-nitrosothiols inhibit cytokine-mediated induction of matrix metalloproteinase-9 in airway epithelial cells. Am J Respir Cell Mol Biol (2002) 0.84
Bradykinin increases IL-8 generation in airway epithelial cells via COX-2-derived prostanoids. Am J Physiol Lung Cell Mol Physiol (2002) 0.84
Regulation of gelatinases in human airway smooth muscle cells: mechanism of progelatinase A activation. Am J Physiol (1999) 0.84
Release of cytokines from isolated lung strips by bradykinin. Inflamm Res (1995) 0.82
Inhibitory effect of a novel bradykinin B1 receptor antagonist, R-954, on enhanced vascular permeability in type 1 diabetic mice. Can J Physiol Pharmacol (2002) 0.82
Regulation of expression of matrix metalloproteinase-9 in early human T cells of the HSB.2 cultured line by the EP3 subtype of prostaglandin E2 receptor. J Biol Chem (1996) 0.82
Kinin B1 receptor antagonists inhibit diabetes-induced hyperalgesia in mice. Neuropeptides (2003) 0.81
Efficacy and tolerability of Icatibant (Hoe 140) in patients with moderately severe chronic bronchial asthma. Immunopharmacology (1996) 0.81
Prostaglandin E2 stimulates expression of matrix metalloproteinase 2 in cultured rat mesangial cells. Kidney Int (1997) 0.81
Effect of Hoe 140, a new bradykinin receptor antagonist, on bradykinin- and platelet-activating factor-induced bronchoconstriction and airway microvascular leakage in guinea pig. Eur J Pharmacol (1992) 0.81
Prostanoid-induced expression of matrix metalloproteinase-1 messenger ribonucleic acid in rat osteosarcoma cells. Endocrinology (1994) 0.80
Role of kinins in seasonal allergic rhinitis: icatibant, a bradykinin B2 receptor antagonist, abolishes the hyperresponsiveness and nasal eosinophilia induced by antigen. J Allergy Clin Immunol (2001) 0.79
Implication of the bradykinin receptors in antigen-induced pulmonary inflammation in mice. Br J Pharmacol (2003) 0.78
Bradykinin as a major endogenous regulator of endothelial function. Pediatr Pathol Mol Med (2002) 0.78
[The role of matrix metalloproteinases in extracellular matrix remodelling in chronic obstructive pulmonary disease rat models]. Zhonghua Nei Ke Za Zhi (2002) 0.78
Mechanisms underlying the contraction induced by bradykinin in the guinea pig epithelium-denuded trachea. Can J Physiol Pharmacol (2002) 0.76
Bradykinin stimulates interleukin-6 and interleukin-8 secretion of human decidua derived cells. Br J Obstet Gynaecol (1997) 0.75
Determination of the role of conventional, novel and atypical PKC isoforms in the expression of morphine tolerance in mice. Pain (2006) 1.37
Morphine tolerance in the mouse ileum and colon. J Pharmacol Exp Ther (2008) 1.31
Design, synthesis, and biological evaluation of 6alpha- and 6beta-N-heterocyclic substituted naltrexamine derivatives as mu opioid receptor selective antagonists. J Med Chem (2009) 1.26
PKC and PKA inhibitors reinstate morphine-induced behaviors in morphine tolerant mice. Pharmacol Res (2006) 1.02
Biological and biomedical applications of engineered nucleases. Mol Biotechnol (2013) 0.92
Absence of diabetic hyperalgesia in bradykinin B1 receptor-knockout mice. Regul Pept (2005) 0.88
Role of bradykinin B(1) receptors in diabetes-induced hyperalgesia in streptozotocin-treated mice. Eur J Pharmacol (2002) 0.87
Synthesis and pharmacological evaluation of phenylethynyl[1,2,4]methyltriazines as analogues of 3-methyl-6-(phenylethynyl)pyridine. J Med Chem (2007) 0.87
The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects. Clin Cancer Res (2002) 0.87
Effects of a selective bradykinin B1 receptor antagonist on increased plasma extravasation in streptozotocin-induced diabetic rats: distinct vasculopathic profile of major key organs. Eur J Pharmacol (2005) 0.87
The kinin system mediates hyperalgesia through the inducible bradykinin B1 receptor subtype: evidence in various experimental animal models of type 1 and type 2 diabetic neuropathy. Biol Chem (2006) 0.86
Nociceptive tolerance is improved by bradykinin receptor B1 antagonism and joint morphology is protected by both endothelin type A and bradykinin receptor B1 antagonism in a surgical model of osteoarthritis. Arthritis Res Ther (2011) 0.84
Hepcidin increases intracellular Ca2+ of osteoblast hFOB1.19 through L-type Ca2+ channels. Regul Pept (2011) 0.84
Enhanced dermal and retinal vascular permeability in streptozotocin-induced type 1 diabetes in Wistar rats: blockade with a selective bradykinin B1 receptor antagonist. Regul Pept (2005) 0.83
In vivo evaluation of cerebral transplantation of resovist-labeled bone marrow stromal cells in Parkinson's disease rats using magnetic resonance imaging. Appl Biochem Biotechnol (2010) 0.83
Differential modulation of murine lung inflammation by bradykinin B1 and B2 selective receptor antagonists. Eur J Pharmacol (2003) 0.83
Human urotensin-II enhances plasma extravasation in specific vascular districts in Wistar rats. Can J Physiol Pharmacol (2004) 0.82
Inhibitory effect of a novel bradykinin B1 receptor antagonist, R-954, on enhanced vascular permeability in type 1 diabetic mice. Can J Physiol Pharmacol (2002) 0.82
Blockade of early and late retinal biochemical alterations associated with diabetes development by the selective bradykinin B1 receptor antagonist R-954. Peptides (2012) 0.81
Kinin B1 receptor antagonists inhibit diabetes-induced hyperalgesia in mice. Neuropeptides (2003) 0.81
Inhibition of type 1 diabetic hyperalgesia in streptozotocin-induced Wistar versus spontaneous gene-prone BB/Worchester rats: efficacy of a selective bradykinin B1 receptor antagonist. J Neuropathol Exp Neurol (2005) 0.80
[Functional duality of kinin receptors in pathophysiology]. Med Sci (Paris) (2003) 0.79
Hyperalgesia in non-obese diabetic (NOD) mice: a role for the inducible bradykinin B1 receptor. Eur J Pharmacol (2005) 0.79
Triple vasopeptidase inhibition normalizes blood pressure in conscious, unrestrained, and spontaneously hypertensive rats. Am J Hypertens (2005) 0.79
A law of mutation: power decay of small insertions and small deletions associated with human diseases. Appl Biochem Biotechnol (2009) 0.78
Downregulation of ferroportin 1 expression in hFOB1.19 osteoblasts by hepcidin. Inflammation (2012) 0.78
Beneficial effect of chronic treatment with the selective bradykinin B1 receptor antagonists, R-715 and R-954, in attenuating streptozotocin-diabetic thermal hyperalgesia in mice. Peptides (2003) 0.78
Endothelin, PAF and thromboxane A2 in allergic pulmonary hyperreactivity in mice. Prostaglandins Leukot Essent Fatty Acids (2007) 0.78
Prostaglandins, leukotrienes and PAF selectively modulate lymphocyte subset and eosinophil infiltration into the airways in a murine model of asthma. Prostaglandins Leukot Essent Fatty Acids (2007) 0.78
Antidiabetic efficacy of bradykinin antagonist R-954 on glucose tolerance test in diabetic type 1 mice. Neuropeptides (2010) 0.78
Implication of the bradykinin receptors in antigen-induced pulmonary inflammation in mice. Br J Pharmacol (2003) 0.78
Profile of endothelin isopeptides and markers of oxidative stress alongside the onset of streptozotocin-type I diabetes in rats. J Cardiovasc Pharmacol (2004) 0.77
Endothelins mediate neutrophil activation, ProMMP-9 release and endothelial cell detachment. Inflammation (2007) 0.77
Effects of angiotensin-converting enzyme inhibitor plus irbesartan on maximal and submaximal exercise capacity and neurohumoral activation in patients with congestive heart failure. Am Heart J (2005) 0.77
Bradykinin B₁ antagonism inhibits oxidative stress and restores Na+K+ ATPase activity in diabetic rat peripheral nervous system. Peptides (2013) 0.77
A new strategy for next generation sequencing: merging the Sanger's method and the sequencing by synthesis through replacing extension. J Biomed Nanotechnol (2011) 0.77
The bradykinin B1 receptor antagonist R-954 inhibits Ehrlich tumor growth in rodents. Peptides (2011) 0.77
Transforming viral sequences to A (H1N1) flu diagnosis: the current status and future prospects of rtPCR based assays. Curr Pharm Biotechnol (2010) 0.76
Role of airway eosinophilia and eosinophil activation in Sephadex-induced inflammation. Inflammation (2004) 0.76
Des-Arg9-bradykinin increases intracellular Ca2+ in bronchoalveolar eosinophils from ovalbumin-sensitized and -challenged mice. Eur J Pharmacol (2003) 0.76
Role of CD38, a cyclic ADP-ribosylcyclase, in morphine antinociception and tolerance. J Pharmacol Exp Ther (2010) 0.75
Bradykinin B(1) receptor antagonist R954 inhibits eosinophil activation/proliferation/migration and increases TGF-beta and VEGF in a murine model of asthma. Neuropeptides (2009) 0.75
Inhibition of prostaglandin G/H synthase unveils a potent effect of platelet activating factor on the permeability of bovine aortic endothelial cells to albumin. Inflammation (2002) 0.75
An excess of G over C nucleotides in mutagenesis of human genetic diseases. Mol Biotechnol (2011) 0.75
Integrated in vivo pharmacology using an instrumented, unrestrained and conscious rat platform: application to rat models of diabetes. J Pharmacol Toxicol Methods (2005) 0.75
Inhibition of basal and stimulated release of endothelin-1 from guinea pig tracheal epithelial cells in culture by beta 2-adrenoceptor agonists and cyclic AMP enhancers. Inflammation (2007) 0.75
CRISPR/Cas: A Faster and More Efficient Gene Editing System. J Nanosci Nanotechnol (2015) 0.75
Understanding of and possible strategies to avian influenza outbreak. Curr Pharm Biotechnol (2013) 0.75
The updated concept of genome and its implications in biotechnological research and molecular diagnostics. Mol Biotechnol (2008) 0.75
Triple vasopeptidase inhibition of angiotensin-converting enzyme/neutral endopeptidase/endothelin-converting enzyme activities on the hemodynamic profile of chronically instrumented unrestrained conscious spontaneously hypertensive rats. J Cardiovasc Pharmacol (2004) 0.75